- Conditions
- Partial-Onset or Primary Generalized Tonic-Clonic Seizures
- Interventions
- Perampanel
- Drug
- Lead sponsor
- Eisai Inc.
- Industry
- Eligibility
- 4 Years to 12 Years
- Enrollment
- 180 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2021
- U.S. locations
- 29
- States / cities
- Little Rock, Arkansas • Palo Alto, California • Aurora, Colorado + 25 more
Source: ClinicalTrials.gov public record
Updated Oct 27, 2022 · Synced May 22, 2026, 3:51 AM EDT